Orthopedics This Week
VOLUME 12, ISSUE 27
AUGUST 23, 2016
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: BLVKF) recently posted a smoking 110% increase in stock value over 30 days, securing the #1 rank as a top performing in “Orthopedics This Week” on publisher Robin Young’s Universe list in Issue 27. See the issue here (page 3.)
This comes just days before Lattice announces its third quarter 2016 highlights where new core product sales have increased 205% quarter over quarter.
This distinction comes as a special honor to our team. Since taking the company public at the beginning of the year, we have been dedicated to creating a strong stock value by focusing on product innovation, processing capabilities, and surgeon relationships so that we can best support the gift of life for patients everywhere. Thank you, OTW!
About “Orthopedics This Week”
Four time winner of the MORE award for journalistic excellence, Orthopedics This Week is the essential and most widely read publication in Orthopedics. Forty times a year, OTW delivers breaking news, analysis and commentary. Now the largest sector in all of medicine with more than 75 million patients treated in the U.S. annually (2.3x that number globally), this is an industry that affects roughly 1 in 4 people. From stem cells to war time surgery to medical tourism to clinical ethics, Orthopedics is at the leading edge of what matters most in healthcare. Orthopedics This Week is THE weekly news and commentary newsletter for all that is unique and valuable to professionals who get up every day and work in the orthopedic community.
See the issue here (page 3.)
Follow us on Twitter: @LatticeBio
Melanie Battista, Public Relations, Lattice Biologics Ltd., (TSX-V: LBL) (OTCBB: BLVKF)
16701 N 90th Street, Suite #101, Scottsdale, AZ 85260, 480-563-0800 Office
News@LatticeBiologics.com | www.LatticeBiologics.com